Zyoxel Ltd
Zyoxel is an early-stage cell culture products and services business based on technologies developed within the Institute of Biomedical Engineering, University of Oxford.
Their core technology is TissueFlex®, a cell culture consumable enabling parallel testing of cells grown in a 3D, perfused state. Zyoxel is developing next generation tools for more efficient and accurate drug and chemical toxicity and efficacy testing.
Zyoxel's current focus is on further developing and expanding their proof-of-principle applications through collaborations with the end user community in the pharmaceutical, chemical testing and cell culture sectors.
Press Release: Hong Kong Multinational Invests in Oxford Bioengineering Spin-out